Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  New England Journal of Medicine

• Publication date

  2008-09-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMoa0804602PMID 18765433
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analyses of cancer data from three ezetimibe trials.

  2009cited by this paper
• Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy).

  2008cited by this paper
• Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis.

  2008cited by this paper
• Analyses of cancer data from three ezetimibe trials.

  2008cited by this paper
• Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.

  2007cited by this paper
• Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.

  2007cited by this paper
• Calcific aortic stenosis: an update

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Guidelines on the management of valvular heart disease.

  2007cited by this paper
• Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.

  2007cited by this paper
• Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology

  2006cited by this paper
• Sweden

  2006cited by this paper
• Calcified Rheumatic Valve Neoangiogenesis Is Associated With Vascular Endothelial Growth Factor Expression and Osteoblast-Like Bone Formation

  2005cited by this paper
• Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio

  2005cited by this paper
• Giorgio's paradox.

  2005cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.

  2005cited by this paper
• Mutations in NOTCH1 cause aortic valve disease

  2005cited by this paper
• Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis

  2004cited by this paper
• Aortic stenosis: even mild disease is significant.

  2004cited by this paper
• Association of cardiovascular risk factors to aortic valve calcification as quantified by electron beam computed tomography.

  2004cited by this paper
• Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype

  2003cited by this paper
• Association Between Apolipoprotein E Alleles and Calcific Valvular Heart Disease

  2003cited by this paper
• Atorvastatin Inhibits Hypercholesterolemia-Induced Cellular Proliferation and Bone Matrix Production in the Rabbit Aortic Valve

  2002cited by this paper
• The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening.

  2002cited by this paper
• HMG CoA reductase inhibitor (statin) and aortic valve calcium.

  2002cited by this paper
• Effect of Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors on the Progression of Calcific Aortic Stenosis

  2001cited by this paper
• Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study.

  2001cited by this paper
• Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting.

  2001cited by this paper
• New insights into the progression of aortic stenosis: implications for secondary prevention.

  2000cited by this paper
• New insights into the progression of aortic stenosis: implications for secondary prevention.

  2000cited by this paper
• Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly.

  1999cited by this paper
• Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves.

  1999cited by this paper
• Learning to recognize objects.

  1999cited by this paper
• Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

  1997cited by this paper
• Clinical Factors Associated With Calcific Aortic Valve Disease

  1997cited by this paper
• Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis.

  1996cited by this paper
• Osteopontin is expressed in human aortic valvular lesions.

  1995cited by this paper
• Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves.

  1994cited by this paper
• Characterization of the Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis: Histological and Immunohistochemical Studies

  1994cited by this paper
• Expression of HLA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis.

  1994cited by this paper
• Factors associated with calcific aortic valve degeneration in the elderly.

  1994cited by this paper
• Clinical factors useful in predicting aortic valve structure in patients > 40 years of age with isolated valvular aortic stenosis.

  1993cited by this paper
• Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

  1993cited by this paper
• Development and progression of aortic valve stenosis: Atherosclerosis risk factors—a causal relationship? a clinical morphologic study

  1991cited by this paper
• Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography.

  1989cited by this paper
• Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients.

  1987cited by this paper
• Case-control analysis of risk factors for presence of aortic stenosis in adults (age 50 years or older).

  1985cited by this paper
• Diabetes and hypercholesterolemia among patients with calcific aortic stenosis.

  1984cited by this paper
• Errata

  1805cited by this paper

• Interplay between medical and interventional therapies in valvular heart disease and heart failure: an expert opinion paper.

  2026cites this paper
• The effects of cholesterol-lowering drugs on neurocognitive function: systematic review and meta analysis.

  2026cites this paper
• Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials: A meta-analysis.

  2026cites this paper
• Preclinical Mouse Models in Calcific Aortic Valve Disease: Bridging Pathophysiology and Therapeutic Innovation

  2026cites this paper
• Circulating biomarkers in serum from aortic valve stenosis patients predict sex-specific drug responses in valve myofibroblasts

  2026cites this paper
• Valvular heart failure: evolving pharmacological approaches.

  2026cites this paper
• Cumulative LDL cholesterol exposure and the risk of coronary artery lesion progression: a linear association

  2026cites this paper
• Dissecting sexual dimorphism in aortic valve stenosis by proteomics

  2025cites this paper
• A scoping review evaluating the current state of gut microbiota and its metabolites in valvular heart disease physiopathology

  2025cites this paper
• Construction and Verification of a Predictive Model for the Progression of Aortic Valve Calcification

  2025cites this paper
• Prevalence and Common Cardiovascular Risk Factors in Aortic Valve Calcification in the Middle-aged General Population.

  2025cites this paper
• Dysglycaemia and incident aortic stenosis: a cohort study

  2025cites this paper
• Association between triglyceride-glucose-body mass index and risk of aortic stenosis progression in patients with non-severe aortic stenosis: a retrospective cohort study

  2025cites this paper
• Clinical, Echocardiographic, and Socioeconomic Predictors of Progression and Outcomes in Patients With Moderate Aortic Stenosis

  2025cites this paper
• Mechanisms of VIC in CAVD analyzed by single-cell sequencing combined with transcriptome analysis

  2025cites this paper
• Valvular Interstitial Cells as a novel therapeutic target for preventing Calcific Aortic Valve Disease.

  2025cites this paper
• Remnant cholesterol lowering in cardiovascular disease risk reduction in statin, ezetimibe, and PCSK9 inhibitor trials: meta-regression analyses.

  2025cites this paper
• Artificial Intelligence-Enabled Echocardiography as a Surrogate for Multimodality Aortic Stenosis Imaging: Post Hoc Analysis of a Clinical Trial.

  2025cites this paper
• Distinct lipoprotein contributions to valvular heart disease: Insights from genetic analysis.

  2025cites this paper
• Artificial intelligence-enabled echocardiography as a surrogate for multi-modality aortic stenosis imaging: post-hoc analysis of a clinical trial

  2025cites this paper
• Decoding calcific aortic valve disease: is liver X receptor the key to lipid metabolism?

  2025cites this paper
• Unraveling the Link Between Aortic Stenosis and Atherosclerosis: What Have We Learned?

  2025cites this paper
• Lp(a): A clinical review.

  2025cites this paper
• High-Intensity Statins Promote PCSK9 Secretion and Aortic Valve Calcification in Patients with Severe Aortic Stenosis: In vitro and Clinical Evidence.

  2025cites this paper
• Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies

  2025cites this paper
• Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis.

  2025cites this paper
• Serum Alpha-1-microglobulin (A1M) as an independent predictor of calcific aortic valve stenosis and its diagnostic value.

  2025cites this paper
• Exosomal NAMPT from Engineered Mesenchymal Stem Cells Mitigates Aortic Stenosis via Metabolic and Anti-Inflammatory Pathways

  2025cites this paper
• Significance of APOB/APOA1 Ratio in the Prediction of Calcific Aortic Valve Disease

  2025cites this paper
• Management of dyslipidaemia in patients with comorbidities: facing the challenge: type 2 diabetes mellitus

  2025cites this paper
• Renal Dysfunction, Arterial Stiffness, and the Interpretation of "Global Afterload" in Moderate Aortic Stenosis - What's Old is New Again.

  2025cites this paper
• Testing if vitamin K1 reduces the progression of non-severe calcific aortic stenosis: design and rationale of the Prevention of Aortic Stenosis Progression Phylloquinone Ossification Reduction Trial (PASSPORT)

  2025cites this paper
• Potential and Future Therapeutic Applications of Eicosapentaenoic/Docosahexaenoic Acid and Probiotics in Chronic Low-Grade Inflammation

  2025cites this paper
• Oxidized LDL-induced FOXS1 mediates cholesterol transport dysfunction and inflammasome activation to drive aortic valve calcification

  2025cites this paper
• Impact of Triglycerides and Remnant Particles on Hemodynamic Valve Deterioration After Transcatheter Aortic Valve Replacement

  2025cites this paper
• Opening Up the Future of Valvular Heart Disease.

  2025cites this paper
• Genomic and transcriptomic analyses of aortic stenosis enhance therapeutic target discovery and disease prediction

  2025cites this paper
• The predictive value of serum lipoprotein(a) level for new-onset aortic valve calcification in patients with coronary artery disease

  2025cites this paper
• Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment Strategy to Slow Progression of Calcific Aortic Valve Stenosis: Preclinical and Randomized Clinical Trials to Assess Safety and Efficacy

  2025cites this paper
• SGLT2 Inhibition in Aortic Stenosis: A Therapy for the Ventricle, the Valve, or Both?

  2025cites this paper
• Lipid treatment

  2025cites this paper
• Lipoprotein (a) Distribution in Aortic Stenosis Patients

  2025cites this paper
• Thrombospondin-1 Silencing Ameliorates Osteoblastic Differentiation of Aortic Valve Interstitial Cells via Inhibiting Nuclear Factor-κB Pathway

  2025cites this paper
• Diabetes and calcific aortic valve disease: implications of glucose-lowering medication as potential therapy

  2025cites this paper
• Consenso de Cardiopatías en el Geronte / Versión resumida

  2025cites this paper
• Plasma metabolomics uncovers key metabolites and enhances prediction of aortic stenosis: insights from prospective cohort and Mendelian randomisation studies

  2025cites this paper
• The Pathophysiologic Basis and Management of Calcific Aortic Valve Stenosis: JACC State-of-the-Art Review.

  2025cites this paper
• Determining sex differences in aortic valve myofibroblast responses to drug combinations identified using a digital medicine platform

  2025cites this paper
• Long-Term Outcomes in Aortic Stenosis: Mortality Analysis in a Selected Patient Group

  2025cites this paper
• Navigating the Landscape of Translational Medicine of Calcific Aortic Valve Disease

  2025cites this paper
• Diabetes and calcific aortic valve disease: controversy of clinical outcomes in diabetes after aortic valve replacement

  2025cites this paper
• Bibliometric analysis of treatment modalities in calcific aortic valve stenosis

  2025cites this paper
• Valvular oxidized phospholipids correlate with severity of human aortic valvular stenosis.

  2025cites this paper
• Dynamic Response of Heart Rate Variability to Active Standing in Aortic Valve Disease: Insights from Recurrence Quantification Analysis

  2025cites this paper
• Timing of Medical Therapy for Aortic Stenosis: Too Little Too Late?

  2025cites this paper
• The evolution of lipid-lowering drugs in the management of cardiovascular disease risk: From the first cardiovascular disease risk-reducing therapies to the novel challenging strategies.

  2025cites this paper
• 2025 ESC/EACTS Guidelines for the management of valvular heart disease.

  2025cites this paper
• Valvulopatía aórtica

  2025cites this paper
• Metabolomics of aortic valve stenosis: Are aortic valve stenosis and sclerosis different diseases?

  2025cites this paper
• Aortic Valve Sclerosis and Degenerative Valve Disease in a Nigerian Population: An Echocardiographic Study

  2025cites this paper
• Genetic insights into causal effects of lipids and lipid-modifying targets on calcific aortic valve stenosis: a Mendelian randomized study

  2025cites this paper
• Protective Role of Lipid-Lowering Drugs in Breast Cancer: Effects on Cancer Incidence and Cardiotoxicity

  2025cites this paper
• Sex-specific lipidomic signatures in aortic valve disease reflect differential fibro-calcific progression

  2025cites this paper
• The Effects of Low-Dose Colchicine on the Progression of Aortic Valve Stenosis: Rationale, Design, and Baseline Characteristics of the Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial.

  2025cites this paper
• 2025 ESC/EACTS Guidelines for the management of valvular heart disease.

  2025cites this paper
• A new journal for the cardiovascular community.

  2025cites this paper
• Rationale and Design of the EPISODE Trial: A Randomized Controlled Trial on the Effect of PCSK9 Inhibitors in Calcific Aortic Valve Stenosis

  2025cites this paper
• oxLDL-induced aortic valve inflammation and calcification: opportunities for clinical translation

  2025influential citation
• Effect of Evogliptin on the Progression of Aortic Valvular Calcification.

  2024cites this paper
• Medical Therapy for Aortic Stenosis: Abandon Ship or Full Steam Ahead?

  2024cites this paper
• Unmet needs and knowledge gaps in aortic stenosis: A position paper from the Heart Valve Council of the French Society of Cardiology.

  2024cites this paper
• Rare Genetic Variants in LDLR, APOB, and PCSK9 Are Associated With Aortic Stenosis

  2024cites this paper
• Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in fibro-calcific aortic valve disease

  2024cites this paper
• Current Management and Therapy of Severe Aortic Stenosis and Future Perspective

  2024cites this paper
• Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis

  2024cites this paper
• Causal Relationships between Lipid-Lowering Drug Target and Aortic Disease and Calcific Aortic Valve Stenosis: A Two-Sample Mendelian Randomization

  2024cites this paper
• 2023 Korean Society of Echocardiography position paper for diagnosis and management of valvular heart disease, part I: aortic valve disease

  2024cites this paper
• Calcific aortic valve disease and cardiometabolic triggers: an explanation behind progression of aortic valvular disease and failure of medical therapy interventions

  2024cites this paper
• Noncoding RNA regulates the expression of Krm1 and Dkk2 to synergistically affect aortic valve lesions

  2024cites this paper
• Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond

  2024cites this paper
• Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy Targets: A Scientific Statement From the American Heart Association.

  2024cites this paper
• Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol

  2024cites this paper
• Genetic proxy of lipid-lowering drugs and calcific aortic valve stenosis: A Mendelian randomization study

  2024cites this paper
• In Vivo Three-Dimensional Geometric Reconstruction of the Mouse Aortic Heart Valve

  2024cites this paper
• Lipid lowering for prevention of venous thromboembolism: a network meta-analysis.

  2024cites this paper
• Statins in the Cause and Prevention of Cancer: Confounding by Indication and Mediation by Rhabdomyolysis and Phosphate Toxicity

  2024cites this paper
• Insights into calcific aortic valve stenosis: a comprehensive overview of the disease and advancing treatment strategies

  2024cites this paper
• Pathological Mechanism and Treatment of Calcified Aortic Stenosis

  2024cites this paper
• Benefits and Risks of Antihyperlipidemic Medication in Adults with Different Low-Density Lipoprotein Cholesterol Based on the Number Needed to Treat

  2024cites this paper
• Unraveling the Enigma of Moderate Aortic Stenosis: Challenges and Future Prospects

  2024cites this paper
• An Analysis of the Relationship between Lipoprotein (a) Levels and the Variation of Calcification Volume in Patients with Calcific Aortic Stenosis

  2024cites this paper
• Progressão da doença valvar cardíaca nos pacientes em diálise: como evitá-la?

  2024cites this paper
• Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice.

  2024cites this paper
• Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Variants, Their Serum Levels, and Activities with Aortic Valve Calcification (AVC) in a Population from Western Iran

  2024cites this paper
• Impact of Lipid-Lowering Therapy on Cancer Risk: A Narrative Review.

  2024cites this paper
• Effect of ezetimibe–statin combination therapy vs. statin monotherapy on coronary atheroma phenotype and lumen stenosis in patients with coronary artery disease: a meta-analysis and trial sequential analysis

  2024cites this paper
• Atorvastatin Effect on Aortic Dilatation and Valvular Calcification Progression in Bicuspid Aortic Valve (BICATOR): A Randomized Clinical Trial

  2024cites this paper
• Are We Using Ezetimibe As Much As We Should?

  2024cites this paper
• Molecular Features of Calcific Aortic Stenosis in Female and Male Patients

  2024cites this paper
• Ezetimibe: Integrating Established Use with New Evidence - A Comprehensive Review

  2024cites this paper